RESEARCH TRIANGLE PARK, N.C. & BANGALORE, India--(BUSINESS WIRE)--Advinus Therapeutics, a TATA group, contract research services and pharmaceutical drug discovery company, based in Bangalore, India announced that it has started its US operations by incorporating a wholly owned subsidiary, Advinus Therapeutics Inc. The US Company will be operating out of its office in Research Triangle Park, North Carolina. In addition, the company also announced that it has appointed Dr. Eric Nelson as its Global Head of Business Development, Marketing and Strategy. Dr. Nelson with over 20 years of corporate and business development experience with both large pharmaceutical and biotechnology companies would be based out of the company’s US office and will have the responsibility of managing its operations. Eric joins Advinus from Tranzyme Pharma where he was Vice President of Business Development & Licensing. Previously he was Assistant Vice President of Global Business Development at Wyeth Pharmaceuticals.
